'Metabolically healthy obesity': origins and implications.
暂无分享,去创建一个
[1] A. Belkina,et al. BET domain co-regulators in obesity, inflammation and cancer , 2012, Nature Reviews Cancer.
[2] D. Chisholm,et al. The metabolically obese, normal-weight individual revisited. , 1998, Diabetes.
[3] Stephen J. Weiss,et al. A Pericellular Collagenase Directs the 3-Dimensional Development of White Adipose Tissue , 2006, Cell.
[4] Richard T. Lee,et al. Thioredoxin Regulates Adipogenesis through Thioredoxin-interacting Protein (Txnip) Protein Stability*♦ , 2011, The Journal of Biological Chemistry.
[5] S. Kiechl,et al. U-Shaped and J-Shaped Relationships Between Serum Insulin and Coronary Heart Disease in the General Population: The Bruneck Study , 1998, Diabetes Care.
[6] A. Vidal-Puig,et al. Adipose tissue expandability: the metabolic problems of obesity may arise from the inability to become more obese. , 2008, Biochemical Society transactions.
[7] Y. Hayashi,et al. Adiponectin and AdipoR1 regulate PGC-1α and mitochondria by Ca2+ and AMPK/SIRT1 , 2010, Nature.
[8] F. Liu,et al. Fat-Specific DsbA-L Overexpression Promotes Adiponectin Multimerization and Protects Mice From Diet-Induced Obesity and Insulin Resistance , 2012, Diabetes.
[9] C. Bouchard,et al. Overfeeding in identical twins: 5-year postoverfeeding results. , 1996, Metabolism: clinical and experimental.
[10] C. Herder,et al. Relationship between adipocyte size and adipokine expression and secretion. , 2007, The Journal of clinical endocrinology and metabolism.
[11] Y. Ohnishi,et al. Functional SNPs in the lymphotoxin-α gene that are associated with susceptibility to myocardial infarction , 2003, Nature Genetics.
[12] M. Blüher. Are there still healthy obese patients? , 2012, Current opinion in endocrinology, diabetes, and obesity.
[13] Thomas L. Rothstein,et al. Eμ-BRD2 transgenic mice develop B-cell lymphoma and leukemia , 2004 .
[14] P. Puigserver,et al. Transcriptional regulation of adipogenesis. , 2000, Genes & development.
[15] D. Faller,et al. Bromodomain analysis of Brd2-dependent transcriptional activation of cyclin A. , 2005, The Biochemical journal.
[16] A. Goldfine,et al. Inflammation and insulin resistance. , 2006, The Journal of clinical investigation.
[17] Roger A. Davis,et al. Thioredoxin‐interacting protein deficiency induces Akt/Bcl‐xL signaling and pancreatic beta‐cell mass and protects against diabetes , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[18] Fernando Costa,et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. , 2005, Circulation.
[19] L. Lynch,et al. Preadipocyte factor-1 is associated with metabolic profile in severe obesity. , 2011, The Journal of clinical endocrinology and metabolism.
[20] J. Knight,et al. Regulation of major histocompatibility complex class II gene expression, genetic variation and disease , 2010, Genes and Immunity.
[21] B. Spiegelman,et al. PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. , 1999, Molecular cell.
[22] R. Turner,et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.
[23] J. Deeney,et al. Brd2 gene disruption causes "metabolically healthy" obesity: epigenetic and chromatin-based mechanisms that uncouple obesity from type 2 diabetes. , 2013, Vitamins and hormones.
[24] Tom Britton,et al. Dynamics of fat cell turnover in humans , 2008, Nature.
[25] K. Strissel,et al. Dynamic, M2-Like Remodeling Phenotypes of CD11c+ Adipose Tissue Macrophages During High-Fat Diet–Induced Obesity in Mice , 2010, Diabetes.
[26] T. Funahashi,et al. Natriuretic peptides enhance the production of adiponectin in human adipocytes and in patients with chronic heart failure. , 2009, Journal of the American College of Cardiology.
[27] Jean-Daniel Zucker,et al. Fibrosis in Human Adipose Tissue: Composition, Distribution, and Link With Lipid Metabolism and Fat Mass Loss , 2010, Diabetes.
[28] C. Duman,et al. Endothelial dysfunction in young women with polycystic ovary syndrome: relationship with insulin resistance and low-grade chronic inflammation. , 2004, The Journal of clinical endocrinology and metabolism.
[29] K. Pennert,et al. Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden. , 1984, British medical journal.
[30] H. Masutani,et al. Disruption of TBP-2 ameliorates insulin sensitivity and secretion without affecting obesity , 2010, Nature communications.
[31] T. Miyazaki,et al. AIMing at Metabolic Syndrome , 2011 .
[32] A Tremblay,et al. The response to long-term overfeeding in identical twins. , 1990, The New England journal of medicine.
[33] T. Iwanaga,et al. Macrophage-derived AIM is endocytosed into adipocytes and decreases lipid droplets via inhibition of fatty acid synthase activity. , 2010, Cell metabolism.
[34] M. Blüher. The distinction of metabolically ‘healthy’ from ‘unhealthy’ obese individuals , 2010, Current opinion in lipidology.
[35] Richard N Bergman,et al. Why Visceral Fat is Bad: Mechanisms of the Metabolic Syndrome , 2006, Obesity.
[36] K. Clément,et al. Adipose tissue transcriptomic signature highlights the pathological relevance of extracellular matrix in human obesity , 2008, Genome Biology.
[37] D. Cibula,et al. Insulin sensitivity in women with polycystic ovary syndrome. , 2004, The Journal of clinical endocrinology and metabolism.
[38] B. Zinman,et al. Obesity Is a Major Determinant of the Association of C-Reactive Protein Levels and the Metabolic Syndrome in Type 2 Diabetes , 2006, Diabetes.
[39] M. Birnbaum,et al. Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin , 2011, Nature Medicine.
[40] Julia K Mader,et al. Adipose tissue, inflammation and cardiovascular disease. , 2010, Revista da Associacao Medica Brasileira.
[41] D. DuBois,et al. Adipose Tissue Deficiency and Chronic Inflammation in Diabetic Goto-Kakizaki Rats , 2011, PloS one.
[42] M. Desai,et al. Obesity is associated with macrophage accumulation in adipose tissue. , 2003, The Journal of clinical investigation.
[43] L. Tartaglia,et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. , 2003, The Journal of clinical investigation.
[44] Y. Matsuzawa. Therapy Insight: adipocytokines in metabolic syndrome and related cardiovascular disease , 2006, Nature Clinical Practice Cardiovascular Medicine.
[45] Y. Deshaies,et al. A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity. , 2004, Endocrinology.
[46] T. Miyazaki,et al. AIMing at metabolic syndrome. -Towards the development of novel therapies for metabolic diseases via apoptosis inhibitor of macrophage (AIM).-. , 2011, Circulation journal : official journal of the Japanese Circulation Society.
[47] Bohan Wang,et al. Hypoxia in adipose tissue: a basis for the dysregulation of tissue function in obesity? , 2008, British Journal of Nutrition.
[48] E. A. Sims,et al. Are there persons who are obese, but metabolically healthy? , 2001, Metabolism: clinical and experimental.
[49] Fernando Costa,et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. , 2006, Current opinion in cardiology.
[50] J. Colwell. Multifactorial aspects of the treatment of the type II diabetic patient. , 1997, Metabolism: clinical and experimental.
[51] A Tremblay,et al. Visceral Obesity in Men: Associations With Glucose Tolerance, Plasma Insulin, and Lipoprotein Levels , 1992, Diabetes.
[52] J. Després,et al. Elevated C-Reactive Protein: Another Component of the Atherothrombotic Profile of Abdominal Obesity , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[53] Ricardo Azziz,et al. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis , 2011, Nature Reviews Endocrinology.
[54] R. Abbott,et al. CENTRAL OBESITY AND CORONARY HEART DISEASE IN MEN , 1987, The Lancet.
[55] C. Peterson,et al. Adipose tissue macrophages in insulin resistant subjects are 1 associated with collagen VI, fibrosis and demonstrate 2 alternative activation , 2010 .
[56] F. Wong-Staal,et al. Isoginkgetin enhances adiponectin secretion from differentiated adiposarcoma cells via a novel pathway involving AMP-activated protein kinase. , 2007, The Journal of endocrinology.
[57] H. Oflaz,et al. Determination of endothelial function and early atherosclerotic changes in healthy obese women. , 2003, Diabetes, nutrition & metabolism.
[58] G. Sesti,et al. Insulin Secretion in Metabolically Obese, but Normal Weight, and in Metabolically Healthy but Obese Individuals , 2008, Obesity.
[59] Xu Yan,et al. Enhanced transforming growth factor-beta signaling and fibrogenesis in ovine fetal skeletal muscle of obese dams at late gestation. , 2010, American journal of physiology. Endocrinology and metabolism.
[60] Nader Rifai,et al. Plasma adiponectin levels and risk of myocardial infarction in men. , 2004, JAMA.
[61] D. Bowen,et al. Uncoupling Obesity from Cancer: Bromodomain Co-regulators That Control Inflammatory Networks , 2013 .
[62] Hakon Hakonarson,et al. Genome-wide association studies in type 1 diabetes , 2009, Current diabetes reports.
[63] Wei Zhang,et al. The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis , 2009, BMC public health.
[64] G. Denis,et al. The outliers become a stampede as immunometabolism reaches a tipping point , 2012, Immunological reviews.
[65] C. Block,et al. Mechanisms linking obesity with cardiovascular disease , 2006, Nature.
[66] A. Garg. Adipose tissue dysfunction in obesity and lipodystrophy. , 2006, Clinical cornerstone.
[67] L. Luzi,et al. Prevalence, Metabolic Features, and Prognosis of Metabolically Healthy Obese Italian Individuals , 2010, Diabetes Care.
[68] G. Reaven,et al. Insulin Resistance and Hyperinsulinemia , 2008, Diabetes Care.
[69] A. Işık,et al. Serum adiponectin and vaspin levels in rheumatoid arthritis. , 2010, Archives of medical research.
[70] Pardis C Sabeti,et al. A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC , 2006, Nature Genetics.
[71] D. Goulis,et al. Adiponectin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis. , 2009, Human reproduction update.
[72] Kayoung Lee. Metabolically obese but normal weight (MONW) and metabolically healthy but obese (MHO) phenotypes in Koreans: characteristics and health behaviors. , 2009, Asia Pacific journal of clinical nutrition.
[73] Ralph B D'Agostino,et al. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. , 2006, The Journal of clinical endocrinology and metabolism.
[74] Gretchen A. Stevens,et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants , 2011, The Lancet.
[75] C. Aguilar-Salinas,et al. High adiponectin concentrations are associated with the metabolically healthy obese phenotype. , 2008, The Journal of clinical endocrinology and metabolism.
[76] J. Vague. Sexual differentiation; Factor determining forms of obesity. , 1947 .
[77] Jacqueline Capeau,et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. , 2006, European cytokine network.
[78] V. Hombach,et al. T-lymphocyte Infiltration in Visceral Adipose Tissue: A Primary Event in Adipose Tissue Inflammation and the Development of Obesity-Mediated Insulin Resistance , 2008, Arteriosclerosis, thrombosis, and vascular biology.
[79] Mahboob Rahman,et al. Diabetes mellitus and insulin resistance in patients with rheumatoid arthritis: Risk reduction in a chronic inflammatory disease , 2011, Arthritis care & research.
[80] N. LeBrasseur,et al. Brd2 disruption in mice causes severe obesity without Type 2 diabetes. , 2009, The Biochemical journal.
[81] C. Bouchard,et al. Genetic aspects of susceptibility to obesity and related dyslipidemias , 1992, Molecular and Cellular Biochemistry.
[82] G. Shulman,et al. Tumor Progression Locus 2 (TPL2) Regulates Obesity-Associated Inflammation and Insulin Resistance , 2011, Diabetes.
[83] R. Ross,et al. Effects of Weight Loss Among Metabolically Healthy Obese Men and Women , 2010, Diabetes Care.
[84] C. Bouchard,et al. Role of Deep Abdominal Fat in the Association Between Regional Adipose Tissue Distribution and Glucose Tolerance in Obese Women , 1989, Diabetes.
[85] Richard T. Lee,et al. Deletion of the α-Arrestin Protein Txnip in Mice Promotes Adiposity and Adipogenesis While Preserving Insulin Sensitivity , 2010, Diabetes.
[86] C. Duman,et al. Endothelial dysfunction in young women with polycystic ovary syndrome: relationship with insulin resistance and low-grade chronic inflammation. , 2005, The Journal of clinical endocrinology and metabolism.
[87] O. Ohara,et al. Apoptosis inhibitor of macrophage (AIM) is required for obesity-associated recruitment of inflammatory macrophages into adipose tissue , 2011, Proceedings of the National Academy of Sciences.
[88] M. Quinn,et al. Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review. , 2011, Rheumatology.
[89] Simon C. Potter,et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis , 2011, Nature.
[90] S. Wild,et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. , 2004, Diabetes care.
[91] C. Bogardus,et al. A Genome‐Wide Association Study of BMI in American Indians , 2011, Obesity.
[92] N. Ruderman,et al. The "metabolically-obese," normal-weight individual. , 1981, The American journal of clinical nutrition.
[93] Remi Rabasa-Lhoret,et al. The metabolically healthy but obese individual presents a favorable inflammation profile. , 2005, The Journal of clinical endocrinology and metabolism.
[94] G. Shulman,et al. Obesity-associated improvements in metabolic profile through expansion of adipose tissue. , 2007, The Journal of clinical investigation.
[95] M. Fasshauer,et al. Insulin-sensitive obesity. , 2010, American journal of physiology. Endocrinology and metabolism.
[96] Y. Matsuzawa,et al. Pathophysiology and molecular mechanisms of visceral fat syndrome: the Japanese experience. , 1997, Diabetes/metabolism reviews.
[97] Peter Tontonoz,et al. Fat and beyond: the diverse biology of PPARgamma. , 2008, Annual review of biochemistry.
[98] B. Spiegelman,et al. PPARγ Is Required for the Differentiation of Adipose Tissue In Vivo and In Vitro , 1999 .
[99] N. Ruderman,et al. Obesity-associated disorders in normal-weight individuals: some speculations. , 1982, International journal of obesity.
[100] E. Ravussin,et al. Decreased Expression of Adipogenic Genes in Obese Subjects with Type 2 Diabetes , 2006, Obesity.
[101] Eric Ravussin,et al. Adipose tissue collagen VI in obesity. , 2009, The Journal of clinical endocrinology and metabolism.
[102] R. Krauss,et al. Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement , 2005, Current opinion in cardiology.
[103] B. Spiegelman,et al. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. , 1993, Science.
[104] Y. Matsuzawa,et al. Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. , 1987, Metabolism: clinical and experimental.
[105] A. Eliopoulos,et al. Tpl2 kinase signal transduction in inflammation and cancer. , 2011, Cancer letters.
[106] Shupei Wang,et al. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans Published, JLR Papers in Press, September 8, 2005. DOI 10.1194/jlr.M500294-JLR200 , 2005, Journal of Lipid Research.
[107] A. Belkina,et al. Obesity genes and insulin resistance. , 2010, Current opinion in endocrinology, diabetes, and obesity.
[108] D. Fuchs,et al. Inflammation, adiponectin, obesity and cardiovascular risk. , 2010, Current medicinal chemistry.
[109] Philipp E. Scherer,et al. Metabolic Dysregulation and Adipose Tissue Fibrosis: Role of Collagen VI , 2008, Molecular and Cellular Biology.
[110] G. Denis. Bromodomain coactivators in cancer, obesity, type 2 diabetes, and inflammation. , 2010, Discovery medicine.
[111] B. Wajchenberg. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. , 2000, Endocrine reviews.
[112] Lars Alfredsson,et al. Specific interaction between genotype, smoking and autoimmunity to citrullinated α-enolase in the etiology of rheumatoid arthritis , 2009, Nature Genetics.
[113] A. Attie,et al. Hypoxia-Inducible Factor 1α Induces Fibrosis and Insulin Resistance in White Adipose Tissue , 2009, Molecular and Cellular Biology.
[114] A. Butte,et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1 , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[115] K. Reynolds,et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). , 2008, Archives of internal medicine.
[116] D. Lauderdale,et al. Trends in bariatric surgical procedures. , 2005, JAMA.
[117] K. Walsh,et al. Adiponectin Promotes Macrophage Polarization toward an Anti-inflammatory Phenotype* , 2009, The Journal of Biological Chemistry.
[118] R. Cardiff,et al. - BRD 2 transgenic mice develop B-cell lymphoma and leukemia , 2004 .
[119] G. Denis,et al. An emerging role for bromodomain‐containing proteins in chromatin regulation and transcriptional control of adipogenesis , 2010, FEBS letters.
[120] J. Després,et al. Adiponectinemia in visceral obesity: impact on glucose tolerance and plasma lipoprotein and lipid levels in men. , 2005, The Journal of clinical endocrinology and metabolism.
[121] R. Yu,et al. Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters , 2006, International Journal of Obesity.